trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
Published 1 year ago • 105 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:57
the safety and efficacy of iberdomide for the treatment of multiple myeloma
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
5:35
safety & efficacy of cesnicabtagene autoleucel (ari0002h) in r/r multiple myeloma
-
2:16
insights into the safety and efficacy of belantamab mafodotin in systemic al amyloidosis
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
4:59
blood products
-
4:35
updated safety & efficacy data from manifest-2: pelabresib plus ruxolitinib for myelofibrosis
-
4:38
ovg research: legacy
-
3:09
an overview of the toxicities associated with immunotherapy in multiple myeloma
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
1:22
safety and efficacy of cesnicabtagene autoleucel (ari0002h) for r/r mm
-
2:29
the safety and feasibility of car-t & bispecifics in patients with myeloma after prior allosct
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
2:25
pre-clinical activity of ucartcs1 in multiple myeloma
-
1:01
an update on the phase i trial of bms-986393, a novel gprc5d-targeted car-t, in r/r myeloma
-
4:05
mechanism of action of proteasome inhibitors
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
2:08
vaccinations and infection prophylaxis in multiple myeloma
-
1:45
clinical translation of carfilzomib trial data for mm treatment